Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Rizzo WB.

Expert Opin Orphan Drugs. 2016 Apr;4(4):395-406.

2.

Sjogren-Larsson syndrome: A rare neurocutaneous disorder.

Subramanian V, Hariharan P, Balaji J.

J Pediatr Neurosci. 2016 Jan-Mar;11(1):68-70. doi: 10.4103/1817-1745.181267.

3.

Disruption of the Sjögren-Larsson Syndrome Gene Aldh3a2 in Mice Increases Keratinocyte Growth and Retards Skin Barrier Recovery.

Naganuma T, Takagi S, Kanetake T, Kitamura T, Hattori S, Miyakawa T, Sassa T, Kihara A.

J Biol Chem. 2016 May 27;291(22):11676-88. doi: 10.1074/jbc.M116.714030.

PMID:
27053112
4.

Sjögren-Larsson syndrome: A study of clinical symptoms in six children.

Srinivas SM, Raju KV, Hiremagalore R.

Indian Dermatol Online J. 2014 Apr;5(2):185-8. doi: 10.4103/2229-5178.131099.

5.

Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.

Rizzo WB.

Biochim Biophys Acta. 2014 Mar;1841(3):377-89. doi: 10.1016/j.bbalip.2013.09.001. Review.

6.

Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Fink JK.

Acta Neuropathol. 2013 Sep;126(3):307-28. doi: 10.1007/s00401-013-1115-8. Review.

7.

The role of fatty aldehyde dehydrogenase in epidermal structure and function.

Rizzo WB.

Dermatoendocrinol. 2011 Apr;3(2):91-9. doi: 10.4161/derm.3.2.14619.

8.

Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion.

Rizzo WB, S'Aulis D, Jennings MA, Crumrine DA, Williams ML, Elias PM.

Arch Dermatol Res. 2010 Aug;302(6):443-51. doi: 10.1007/s00403-009-1022-y.

10.

Pathobiology of the stratum corneum.

Jackson SM, Williams ML, Feingold KR, Elias PM.

West J Med. 1993 Mar;158(3):279-85. Review.

Items per page

Supplemental Content

Support Center